Nitrous oxide-induced subacute combined degeneration of the cord: diagnosis and treatment.
Author
Paris, AlvarLake, Luke
Joseph, Albert
Workman, Anna
Walton, Joseph
Hayton, Tom
Evangelou, Nikos
Nicholl, David
Ayling, Ruth M.
Lilleker, James B.
Noyce, Alastair J.
Publication date
2023-02-22Subject
Neurology
Metadata
Show full item recordAbstract
Recreational use of nitrous oxide (N2O) has increased rapidly in recent years and is now the second most commonly used recreational drug among young people in the UK. There has been a corresponding rise in cases of nitrous oxide-induced subacute combined degeneration of the cord (N2O-SACD), a pattern of myeloneuropathy usually associated with severe vitamin B12 deficiency. This can cause serious and permanent disability in young people but, if recognised early, may be effectively treated. All neurologists should be aware of N2O-SACD and its treatment; however, there are currently no agreed guidelines. Based on our experience in East London, an area of high N2O use, we provide practical advice on its recognition, investigation and treatment.Citation
Paris A, Lake L, Joseph A, Workman A, Walton J, Hayton T, Evangelou N, Lilleker JB, Ayling RM, Nicholl D, Noyce AJ. Nitrous oxide-induced subacute combined degeneration of the cord: diagnosis and treatment. Pract Neurol. 2023 Jun;23(3):222-228. doi: 10.1136/pn-2022-003631. Epub 2023 Feb 22. PMID: 36813556; PMCID: PMC10313972.Type
ArticleAdditional Links
https://pn.bmj.com/content/by/yearPMID
36813556Journal
Practical NeurologyPublisher
BMJ Publishing Groupae974a485f413a2113503eed53cd6c53
10.1136/pn-2022-003631